You are currently here:

You are here


You are here

Advocacy and community

True partnerships from beginning to end

Extended basic page

Explore other content within Oncology  

Block before Body

Supporting the needs of patients

We work closely with patient advocates, professional organizations, policy makers, and foundations to better understand the needs of patients, families, caregivers, and others impacted by cancer and find ways to meet those needs.
We encourage our partners to share best practices and work together to achieve patient-centric solutions. Our goal is to provide the educational, emotional, and psychosocial resources that can make a real difference in patient outcomes.
We also provide millions of dollars in grants each year to fund organizations that provide essential programs and services to patients coping with a wide range of cancers.


Blocks after Body

Patients need more than medicine

Treating cancer takes more than just the right medicine. Patients also need emotional and educational support to make it through the day-to-day. That’s why Pfizer has made it a global priority to provide patients with diverse support services throughout their cancer journey.
— Freda Lewis-Hall, MD
Chief Medical Officer

Some of our partnerships

Lung Cancer Profiles/United We Test Quest

AVON Foundation for Women

Breast Cancer: A Story Half Told

Cancer Support Community (CSC)/The Leukemia & Lymphoma Society (LLS)

ASCO/Conquer Cancer Foundation (CCF)

Union for International Cancer Control (UICC)

Susan G. Komen

Joining forces to speed advances and breakthrough medicines to patients

At Pfizer, we know we can’t go at it alone and are actively supporting the development of an emerging, highly networked ecosystem that will catalyze tomorrow’s health innovation.
This includes working with patient foundations, patients, government, payers, healthcare professionals, academia, and even some of our competitors in the biopharmaceutical industry.

Challenging our colleagues to do more

The Global Health Fellows (GHF) program is an international corporate volunteer program that places Pfizer colleagues in short-term fellowships with international development organizations. Fellows return with experience and relationships that help inform their ability to have an impact on pressing health concerns and to do business more efficiently.

Supporting women with metastatic breast cancer (MBC)

In 2015, to address the unique needs of MBC patients worldwide, Pfizer and the UICCa awarded grants totaling $760,000 to 20 organizations from 18 countries under a first-of-its-kind initiative, SPARCb-MBC Challenge.
The challenge aims to empower advocacy groups, hospital networks, support groups, and other organizations to close the gap in information, support, awareness, and policy between MBC and early stage disease, and support women diagnosed with metastatic breast cancer.
aUnion for International Cancer Control.
bSeeding Progress and Resources for the Cancer Community.